MeSH term
Frequency | Condition_Probility | Animals | 96 | 0.0 |
Humans | 96 | 0.0 |
Oligonucleotide Array Sequence Analysis | 6 | 0.0 |
Amino Acid Sequence | 13 | 0.0 |
Bone Morphogenetic Proteins/antagonists & inhibitors/*metabolism | 2 | 40.0 |
Chick Embryo | 9 | 1.0 |
Cloning, Molecular | 8 | 0.0 |
Drosophila | 4 | 1.0 |
Gene Expression Regulation, Developmental | 21 | 1.0 |
Molecular Sequence Data | 24 | 0.0 |
Protein Binding | 6 | 0.0 |
Sequence Alignment | 5 | 0.0 |
Xenopus | 3 | 0.0 |
Bone Density | 2 | 1.0 |
Bone Morphogenetic Proteins/*genetics/metabolism | 3 | 33.0 |
Gene Therapy/*methods | 5 | 1.0 |
Male | 20 | 0.0 |
Rats | 9 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Mice | 62 | 0.0 |
Oligonucleotides, Antisense/pharmacology | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 88 | 0.0 |
Signal Transduction | 14 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Base Sequence | 15 | 0.0 |
Cell Differentiation | 14 | 0.0 |
DNA/metabolism | 2 | 0.0 |
Epithelial Cells/*metabolism | 2 | 1.0 |
Exons | 3 | 0.0 |
Genotype | 4 | 0.0 |
In Situ Hybridization | 19 | 0.0 |
Lac Operon/genetics | 2 | 7.0 |
Luciferases/metabolism | 4 | 0.0 |
Mice, Inbred C57BL | 15 | 0.0 |
Mice, Transgenic | 10 | 0.0 |
*Promoter Regions (Genetics) | 3 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 57 | 0.0 |
Sequence Homology, Nucleic Acid | 4 | 0.0 |
Time Factors | 9 | 0.0 |
beta-Galactosidase/metabolism | 2 | 1.0 |
United States | 3 | 0.0 |
DNA-Binding Proteins/genetics/physiology | 2 | 2.0 |
Mutation | 8 | 0.0 |
Trans-Activation (Genetics) | 4 | 0.0 |
*Trans-Activators | 9 | 1.0 |
Transfection | 6 | 0.0 |
Bone Morphogenetic Proteins/genetics/metabolism | 5 | 41.0 |
Cell Differentiation/*physiology | 3 | 1.0 |
DNA/genetics/metabolism | 2 | 0.0 |
Aged | 4 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Female | 22 | 0.0 |
Middle Aged | 5 | 0.0 |
Bone Morphogenetic Proteins/metabolism | 6 | 11.0 |
Cell Line | 16 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 6 | 0.0 |
Sequence Homology, Amino Acid | 11 | 0.0 |
Transforming Growth Factor beta/*metabolism | 2 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Bone Morphogenetic Proteins/genetics | 7 | 21.0 |
Disease Models, Animal | 4 | 0.0 |
Gene Expression Profiling | 5 | 0.0 |
Genetic Screening | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Helix-Loop-Helix Motifs | 2 | 0.0 |
Mice, Inbred ICR | 3 | 1.0 |
Neurons/*cytology | 2 | 3.0 |
Pregnancy | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
*Proteins | 2 | 0.0 |
*Receptors, Growth Factor | 3 | 9.0 |
*Repressor Proteins | 7 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 11 | 0.0 |
Transcription Factors/genetics | 7 | 0.0 |
*Transforming Growth Factor beta | 13 | 8.0 |
Apoptosis | 3 | 0.0 |
Cell Division | 7 | 0.0 |
*DNA-Binding Proteins | 4 | 0.0 |
Immunohistochemistry | 12 | 0.0 |
Proto-Oncogene Proteins/metabolism | 3 | 0.0 |
Transcription Factors/metabolism | 3 | 0.0 |
Genes, Homeobox | 3 | 3.0 |
Homeodomain Proteins/*genetics | 2 | 0.0 |
Nervous System/*embryology | 4 | 12.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Transcription Factors/*genetics | 6 | 0.0 |
Genes, Reporter | 6 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
beta-Galactosidase/genetics | 2 | 1.0 |
Cell Line, Tumor | 5 | 0.0 |
Chickens | 2 | 0.0 |
Expressed Sequence Tags | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Plasmids/metabolism | 3 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Promoter Regions (Genetics) | 6 | 0.0 |
RNA, Messenger/metabolism | 7 | 0.0 |
Species Specificity | 2 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Zebrafish | 3 | 2.0 |
Cells, Cultured | 11 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Homeodomain Proteins/*metabolism | 2 | 1.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
*Signal Transduction | 10 | 0.0 |
*Transcription Factors | 11 | 0.0 |
*Xenopus Proteins | 8 | 2.0 |
Bone Morphogenetic Proteins/*genetics/*physiology | 2 | 66.0 |
Heterozygote | 6 | 0.0 |
Phenotype | 6 | 0.0 |
Lung/*embryology | 3 | 16.0 |
Mammals | 2 | 0.0 |
Signal Transduction/*physiology | 8 | 0.0 |
Trans-Activators/*physiology | 2 | 0.0 |
Cell Lineage | 3 | 0.0 |
Gene Deletion | 2 | 0.0 |
Multigene Family | 3 | 0.0 |
Cell Count | 3 | 0.0 |
Child | 3 | 0.0 |
Child, Preschool | 3 | 0.0 |
Infant | 3 | 0.0 |
*Body Patterning | 4 | 10.0 |
Proteins/genetics/*physiology | 5 | 3.0 |
Proto-Oncogene Proteins/genetics | 2 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Xenopus/*embryology | 3 | 16.0 |
*Zebrafish Proteins | 3 | 1.0 |
COS Cells | 3 | 0.0 |
Down-Regulation | 2 | 0.0 |
Transcription Factors/genetics/*physiology | 3 | 1.0 |
*Nerve Tissue Proteins | 2 | 0.0 |
Veratrum Alkaloids/pharmacology | 2 | 22.0 |
Immunoblotting | 2 | 0.0 |
Osteogenesis | 3 | 12.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Animals, Newborn | 2 | 0.0 |
Organ Culture Techniques | 7 | 1.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Signal Transduction/drug effects | 4 | 0.0 |
Trans-Activators/genetics/*metabolism | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 6 | 0.0 |
Apoptosis/*physiology | 3 | 0.0 |
Bone Morphogenetic Proteins/*metabolism | 6 | 14.0 |
DNA-Binding Proteins/*metabolism | 5 | 0.0 |
Gene Expression Regulation, Developmental/physiology | 2 | 2.0 |
Mesoderm/cytology/metabolism | 2 | 13.0 |
Signal Transduction/physiology | 3 | 0.0 |
Trans-Activators/metabolism | 5 | 0.0 |
Body Patterning | 4 | 6.0 |
DNA Primers/genetics | 3 | 0.0 |
Embryonic Induction | 3 | 9.0 |
Embryonic and Fetal Development | 4 | 1.0 |
Models, Biological | 4 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
*Drosophila Proteins | 3 | 0.0 |
*Intercellular Signaling Peptides and Proteins | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Adenoviridae/genetics | 3 | 0.0 |
Bone Morphogenetic Proteins/genetics/physiology | 2 | 40.0 |
*Gene Expression Regulation, Developmental | 8 | 1.0 |
Mice, Knockout | 7 | 0.0 |
Mice, Mutant Strains | 4 | 0.0 |
Astrocytes/metabolism | 2 | 2.0 |
Blotting, Western | 4 | 0.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Nerve Tissue Proteins/metabolism | 3 | 1.0 |
Precipitin Tests | 2 | 0.0 |
Bone Morphogenetic Proteins/genetics/*pharmacology/physiology | 2 | 100.0 |
Cell Survival/drug effects | 2 | 0.0 |
Gene Expression | 10 | 0.0 |
Recombinant Proteins/pharmacology | 7 | 0.0 |
Models, Genetic | 3 | 0.0 |
Proteins/*genetics | 7 | 0.0 |
Bone Morphogenetic Proteins/physiology | 2 | 13.0 |
Microinjections | 3 | 1.0 |
Body Patterning/*physiology | 2 | 11.0 |
Mesoderm/physiology | 5 | 14.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Gastrula | 2 | 13.0 |
Phylogeny | 2 | 0.0 |
Biological Markers | 3 | 0.0 |
Culture Techniques | 3 | 0.0 |
Endoderm/*metabolism | 2 | 22.0 |
DNA Primers | 3 | 0.0 |
Embryo, Nonmammalian/physiology | 3 | 10.0 |
Gene Library | 2 | 0.0 |
Mesoderm/*physiology | 3 | 12.0 |
Epithelium | 2 | 3.0 |
Homeodomain Proteins/genetics | 5 | 2.0 |
Mutagenesis | 3 | 0.0 |
Gene Expression Regulation, Developmental/*genetics | 2 | 2.0 |
Mesoderm/metabolism | 2 | 2.0 |
Proteins/*genetics/metabolism | 2 | 0.0 |
Bone Morphogenetic Proteins/genetics/*physiology | 2 | 20.0 |
Bone Morphogenetic Proteins/*pharmacology | 5 | 9.0 |
Mesoderm/drug effects | 2 | 40.0 |
Morphogenesis | 5 | 2.0 |
Transcription Factors/physiology | 4 | 1.0 |
DNA Primers/chemistry | 3 | 0.0 |
Infant, Newborn | 4 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 2 | 0.0 |
Animals, Genetically Modified | 2 | 0.0 |
Cell Movement | 3 | 0.0 |
Syndrome | 3 | 0.0 |
Mice, Inbred C3H | 2 | 0.0 |
Comparative Study | 5 | 0.0 |
Cell Division/drug effects | 5 | 0.0 |
*Embryonic Induction | 2 | 9.0 |
Trans-Activators/genetics | 3 | 1.0 |
Adolescent | 4 | 0.0 |
Genetic Markers | 2 | 0.0 |
Bone Morphogenetic Proteins/*genetics | 4 | 15.0 |
Binding Sites | 2 | 0.0 |
Bone Morphogenetic Proteins/genetics/*metabolism | 5 | 29.0 |
Bone Morphogenetic Proteins/*physiology | 5 | 22.0 |
Phosphoproteins/physiology | 2 | 3.0 |
Adult | 4 | 0.0 |
Drug Synergism | 2 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
NF-kappa B/metabolism | 2 | 0.0 |
*Nuclear Proteins | 3 | 0.0 |
Xenopus/*embryology/genetics | 2 | 40.0 |
Bone and Bones/pathology | 2 | 9.0 |
Gene Expression Regulation, Developmental/genetics | 2 | 2.0 |
Molar/*embryology | 2 | 100.0 |
Epidermis/metabolism | 2 | 5.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Nitriles/pharmacology | 2 | 1.0 |
Bone Morphogenetic Proteins/pharmacology | 2 | 6.0 |
DNA-Binding Proteins/genetics/*physiology | 2 | 0.0 |
Genetic Vectors | 5 | 0.0 |
Skull | 2 | 40.0 |
Mice, Inbred Strains | 2 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
Embryonic and Fetal Development/genetics | 2 | 2.0 |
Cell Survival | 2 | 0.0 |
Homeodomain Proteins/*physiology | 2 | 5.0 |
Tissue Distribution | 2 | 0.0 |
Growth Substances/physiology | 2 | 1.0 |
Odontoblasts/cytology | 2 | 66.0 |
Odontogenesis/*genetics | 2 | 50.0 |
Chimera | 2 | 1.0 |
DNA-Binding Proteins/physiology | 2 | 0.0 |
Mesoderm/cytology | 2 | 5.0 |
In Vitro | 3 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Bone Morphogenetic Proteins | 5 | 20.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Osteogenesis/*drug effects | 2 | 18.0 |
Transduction, Genetic | 2 | 0.0 |
DNA-Binding Proteins/*physiology | 2 | 0.0 |
Trans-Activators/*metabolism | 5 | 0.0 |
Phosphorylation | 3 | 0.0 |
Gene Expression/drug effects | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Pyrroles/pharmacology | 2 | 4.0 |
Oligonucleotide Array Sequence Analysis/methods | 2 | 2.0 |
Ligands | 2 | 0.0 |
Receptors, Growth Factor/metabolism | 2 | 1.0 |
Stem Cells | 2 | 1.0 |
